Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma
Clinical trial NCT04134325 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04134325
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-01
- Primary completion
- 2025-04-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.